Skip to content

An exploratory study to establish new classification and prognosis assessment tools for heart failure

An exploratory study to establish new classification and prognosis assessment tools for heart failure

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2000035563
Enrollment
Unknown
Registered
2020-08-13
Start date
2020-10-01
Completion date
Unknown
Last updated
2020-08-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Heart Failure

Interventions

Case series:N/A

Sponsors

Zhongshan Hospital Affiliated to Fudan University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 120 Years

Inclusion criteria

Inclusion criteria: 1. Patients aged >=18 years old; 2. Patients who sign informed consent form; 3. Patients diagnosed with heart failure during hospitalization are diagnosed according to the 2018 Chinese heart failure guidelines.

Exclusion criteria

Exclusion criteria: 1. Dyspnea caused by non cardiac reasons, such as patients with acute or chronic respiratory dysfunction or infection (such as severe chronic obstructive pulmonary disease, bronchitis, pneumonia), or dyspnea at rest caused by primary pulmonary hypertension; 2. Patients with malignant tumor and the expected survival time is less than 1 year; 3. For pregnant women, pregnancy is defined as the state from pregnancy to termination of pregnancy; 4. Patients who are unable to complete the examinations required by the project during the baseline hospitalization due to various reasons; 5. Patients who fail to comply with the study instructions or follow-up procedures; 6. Any other medical condition that the researcher believes may put the patient at risk or affect the results of the study, or there are medical conditions that are not suitable for the study, including drug or alcohol abuse or mental illness that affect the patient's ability to comply with the protocol or follow-up procedures; 7. Patients who are participating in other studies.

Design outcomes

Primary

MeasureTime frame
Composite endpoint of heart failure readmission or cardiovascular death;

Secondary

MeasureTime frame
Cardiovascular death;All-cause death;Readmission for heart failure;All-cause readmission;Change in quality of life;Change in NT-proBNP level;

Countries

China

Contacts

Public ContactCui Xiaotong

Zhongshan Hospital Affiliated to Fudan University

cuixt021@163.com+86 13681959319

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026